MM

Micah Mackison

Chief Executive Officer

Vico Therapeutics

Indianapolis, Indiana


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Vico Therapeutics
Industry
research
Employees
45.0
Seniority
C suite
Annual Revenue
2000000.0
Total Funding
103295225.0
Latest Funding
Series B

Technologies

Outlook Microsoft Office 365 Google Maps Vimeo Shutterstock Google Font API WordPress.org reCAPTCHA Nginx Google Tag Manager AddThis Google Analytics Mobile Friendly Basis AI

Keywords

biotechnology research rna therapies antisense oligonucleotides neurodegenerative diseases huntington's disease spinocerebellar ataxia polyglutamine disorders gene targeting molecular neuroscience clinical development allele-preferential targeting cag repeat expansion therapeutic development drug discovery biotechnology neuroscience research genetic medicine csf biomarkers huntingtin-lowering therapy precision medicine patient outcomes clinical trials rare genetic disorders mhtt reduction nucleoside chemistry oligonucleotide synthesis therapeutic innovation drug pipeline first-in-class therapies safety & tolerability chd modulating therapies biopharmaceuticals clinical-stage therapies preclinical studies patient-centric approach investigational medicines neuroprotective strategies molecular therapeutics neurological pathology neurodegeneration healthcare investment biotech investment research collaborations orphan drug designation multidisciplinary teams biotech ecosystem therapeutic strategies clinical endpoints health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans